178 related articles for article (PubMed ID: 36830817)
1. Mutual Influence of Human Cytochrome P450 Enzymes and UDP-Glucuronosyltransferases on Their Respective Activities in Recombinant Fission Yeast.
Sharma SS; Sharma S; Zhao J; Bureik M
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830817
[TBL] [Abstract][Full Text] [Related]
2. Mutual Modulation of the Activities of Human CYP2D6 and Four UGTs during the Metabolism of Propranolol.
Yang F; Sharma SS; Bureik M; Parr MK
Curr Issues Mol Biol; 2023 Aug; 45(9):7130-7146. PubMed ID: 37754235
[TBL] [Abstract][Full Text] [Related]
3. Protein-protein interactions between rat hepatic cytochromes P450 (P450s) and UDP-glucuronosyltransferases (UGTs): evidence for the functionally active UGT in P450-UGT complex.
Ishii Y; Iwanaga M; Nishimura Y; Takeda S; Ikushiro S; Nagata K; Yamazoe Y; Mackenzie PI; Yamada H
Drug Metab Pharmacokinet; 2007 Oct; 22(5):367-76. PubMed ID: 17965520
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
[TBL] [Abstract][Full Text] [Related]
5. Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate glucuronosyltransferases.
Kim SB; Kim KS; Kim DD; Yoon IS
Biomed Pharmacother; 2019 Feb; 110():111-117. PubMed ID: 30466000
[TBL] [Abstract][Full Text] [Related]
6. Traditional Herbal Formulas to as Treatments for Musculoskeletal Disorders: Their Inhibitory Effects on the Activities of Human Microsomal Cytochrome P450s and UDP-glucuronosyltransferases.
Jin SE; Seo CS; Shin HK; Ha H
Pharmacogn Mag; 2016; 12(48):241-252. PubMed ID: 27867264
[TBL] [Abstract][Full Text] [Related]
7. Rapid and convenient biotransformation procedure for human drug metabolizing enzymes using permeabilized fission yeast cells.
Sharma S; Durairaj P; Bureik M
Anal Biochem; 2020 Oct; 607():113704. PubMed ID: 32697953
[TBL] [Abstract][Full Text] [Related]
8. Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).
Knights KM; Rowland A; Miners JO
Br J Clin Pharmacol; 2013 Oct; 76(4):587-602. PubMed ID: 23362865
[TBL] [Abstract][Full Text] [Related]
9. Contributions of UDP-Glucuronosyltransferases to Human Hepatic and Intestinal Metabolism of Ticagrelor and Inhibition of UGTs and Cytochrome P450 Enzymes by Ticagrelor and its Glucuronidated Metabolite.
Liu S; Hou L; Li C; Zhao Y; Yao X; Zhang X; Tian X
Front Pharmacol; 2021; 12():761814. PubMed ID: 34721047
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.
Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK
Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066
[TBL] [Abstract][Full Text] [Related]
11. [Protein-Protein Interactions as Underlying Regulatory Mechanisms of Drug-metabolizing Enzyme Function].
Miyauchi Y
Yakugaku Zasshi; 2022; 142(11):1169-1175. PubMed ID: 36328446
[TBL] [Abstract][Full Text] [Related]
12. Relation of Transcriptional Factors to the Expression and Activity of Cytochrome P450 and UDP-Glucuronosyltransferases 1A in Human Liver: Co-Expression Network Analysis.
Zhong S; Han W; Hou C; Liu J; Wu L; Liu M; Liang Z; Lin H; Zhou L; Liu S; Tang L
AAPS J; 2017 Jan; 19(1):203-214. PubMed ID: 27681103
[TBL] [Abstract][Full Text] [Related]
13. Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferases.
Romand S; Spaggiari D; Marsousi N; Samer C; Desmeules J; Daali Y; Rudaz S
J Pharm Biomed Anal; 2017 Sep; 144():129-137. PubMed ID: 27692933
[TBL] [Abstract][Full Text] [Related]
14. The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure.
Zhang M; Rottschäfer V; C M de Lange E
Drug Metab Rev; 2024 Feb; 56(1):1-30. PubMed ID: 38126313
[TBL] [Abstract][Full Text] [Related]
15. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory potential of three Yin-tonification herbal formulas on the activities of human major cytochrome P450 and UDP- glucuronosyltransferases isozymes in vitro.
Seong Eun J; Hyeun-Kyoo S; Hyekyung H
J Tradit Chin Med; 2018 Aug; 38(4):511-522. PubMed ID: 32186076
[TBL] [Abstract][Full Text] [Related]
17. Validated liquid chromatography-tandem mass spectrometry method for determination of totally nine probe metabolites of cytochrome P450 enzymes and UDP-glucuronosyltransferases.
Lee JT; Pao LH; Hsiong CH; Huang PW; Shih TY; Yoa-Pu Hu O
Talanta; 2013 Mar; 106():220-8. PubMed ID: 23598120
[TBL] [Abstract][Full Text] [Related]
18. Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro.
Zeng J; Fan YJ; Tan B; Su HZ; Li Y; Zhang LL; Jiang J; Qiu FR
Acta Pharmacol Sin; 2018 Aug; 39(8):1393-1404. PubMed ID: 29417949
[TBL] [Abstract][Full Text] [Related]
19. The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors.
Liu Y; She M; Wu Z; Dai R
J Enzyme Inhib Med Chem; 2011 Jun; 26(3):386-93. PubMed ID: 20939765
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
